experimental group:rituximab

4 trials

Sponsors

Guangzhou Women and Children Medical Center, Xinqiao Hospital, The First Hospital of China Medical University, The First Affiliated Hospital Of Soochow University

Conditions

Systemic lupus erythematosusThrombotic Thrombocytopenic Purpurabiliary atresiamembranous nephropathy

Phase 1

The multicetre clinical study of the diagnosis,treatment and prognosis evaluation in thrombotic thrombocytopenic purpura.

RecruitingChiCTR-ONRC-13003194

The First Affiliated Hospital Of Soochow UniversityThrombotic Thrombocytopenic Purpura

Start: 2013-07-01Updated: 2017-04-18

Phase 4

A clinical study for Rituximab in the treatment of biliary atresia

RecruitingChiCTR2000031738

Guangzhou Women and Children Medical Centerbiliary atresia

Start: 2020-02-18Updated: 2020-04-13

Efficacy and safety of rituximab in the treatment of primary membranous nephropathy with type 2 diabetes mellitus: a single-center randomized controlled trial.

Active, not recruitingChiCTR2000032523

Xinqiao Hospitalmembranous nephropathy

Start: 2020-06-01Updated: 2020-05-04

Evaluation of the efficacy and safety of low-dose rituximab combined with standard regimen in the treatment of active neuropsychiatric lupus: a prospective, single-arm, single-center clinical study

Active, not recruitingChiCTR2300070865

The First Hospital of China Medical UniversitySystemic lupus erythematosus

Start: 2023-04-30Updated: 2023-06-04